Skip to main content
. 2019 Dec 12;10(1):135–146. doi: 10.1002/2211-5463.12762

Figure 2.

Figure 2

Kaplan–Meier analysis of the relationship between survival and SOX6 expression in patients with lung adenocarcinoma. SOX6 = 1 (staining score ≥ 4), patients with normal levels of SOX6 expression (n = 57; median survival, 36.3 months; brown curve); SOX6 = 0 (staining scores = 0–3), patients with down‐regulation of SOX6 expression (n = 88; median survival, 22.6 months; blue curve); log rank test, P < 0.001.